美国脑积水分流器市场规模和预测、区域份额、趋势和成长机会分析报告范围：按产品、类型、年龄层和最终用户

美国脑积水分流器市场规模预计将从 2022 年的 1.09 亿美元增至 2030 年的 1.46 亿美元。预计 2022 年至 2030 年该市场将以 3.7% 的复合年增长率增长。

市场概况：

脑积水有多种治疗方案，包括：

分流系统：这是一种常见的治疗方法，植入分流器（一根细管），将多余的脑脊髓液从大脑转移到身体的另一个可以吸收的部位。分流技术可能已经取得了进步，以提高其有效性并减少併发症。

内视镜第三脑室造口术（ETV）：这是一种外科手术，在大脑第三脑室底部开一个小孔，让多余的脑脊髓液流出并被吸收。 ETV 用于某些非交通性脑积水病例。

导管脑室造口术：另一种手术选择是将导管直接插入脑室以排出多余的脑脊髓液。

脑室内内视镜检查：内视镜检查等微创技术的进步使得脑积水的诊断和治疗更加精确。

加强治疗脑积水的合作

美国脑积水分流器市场公司正在实施合资和合作等策略，以扩大其市场份额。 2020 年，Aesculap, Inc. 与 Christoph Miethke GmbH & Co. KG (MIETHKE) 合作，共同宣布在美国推出 M.blue 脑积水阀。其独特的重力技术与阀门中的固定压差装置整合在一起，可在患者最活跃的时间根据位置对开启压力进行简单的调整。许多市场参与者专注于开发“智慧分流器”，以了解随时间变化的流量或体积速率。一些行业合作伙伴也在开发使用热稀释来估计通过远端导管的流量以诊断分流故障的设备。因此，越来越多的合作伙伴有助于脑积水分流器的智慧运作，这将导緻美国脑积水分流器市场未来的新趋势。

提高分流品质的研究不断深入

研究人员一直在开发改良的分流材料，以降低阻塞、感染和其他併发症的风险。

抗菌涂层：研究人员一直在研究具有抗菌特性的分流器涂层。这些涂层可以帮助降低植入分流器时感染的风险。

防堵塞机制：有些分流器设计包含防止或减轻阻塞的功能。例如，具有防虹吸机制的阀门可以帮助保持适当的流量并防止过度排水或堵塞。

电磁阀调节：一些分流系统使用磁铁以非侵入性方式调节阀门设置，从而减少重复手术的需要。

生物相容性材料：在分流器结构中使用生物相容性材料可以最大限度地减少身体过敏反应或其他不良反应的风险。

远端监控：远端监控技术的进步可以追踪分流性能和颅内压，帮助医疗保健提供者在问题变得严重之前发现问题。

奈米技术：奈米技术应用已被探索用于製造可抵抗细菌黏附并提高分流器整体耐用性的分流器组件。

例如，2021 年，宾州州立大学的研究人员一直在积极研究一项名为 HydroFix 的突破性技术。这种创新的手术分流系统专门设计用于解决与市场上现有分流装置相关的众多风险。其主要目标是为正常压力脑积水 (NPH) 患者提供持久的治疗解决方案。为了推进这项技术，研究人员成立了一家名为 Cranial Devices Inc. 的新创公司。他们目前正在向宾州州立大学寻求 HydroFix 技术的许可。

同样，Rhaeos, Inc.（一家临床阶段的医疗设备公司）正在开发 FlowSense，这是一项专利技术和一种非侵入性无线可穿戴皮肤贴片。 FlowSense 是一种无线、非侵入性热流量感测器，安装在患者颈部分流器上方，用于检测脑脊髓液的存在和大小。透过 FlowSense，可以在诊所、住院环境和急诊室监测分流功能，从而减少不必要的影像、住院时间和再入院成本。

美国脑积水分流器市场：细分概述

美国脑积水分流器市场成长依产品、类型、年龄层和最终用户细分。依产品，市场分为脑积水瓣膜、脑积水导管、神经导航系统等。脑积水阀进一步分为可调式压力阀和固定压力阀。就类型而言，美国脑积水流器市场分为脑室腹膜分流器、脑室心房分流器、脑室胸膜分流器和腰腹膜分流器。脑室腹腔细分市场将在 2022 年引领市场，并预计在预测期内将保持其主导地位。脑室腹膜 (VP) 分流术透过将脑脊髓液从脑室转移到腹膜腔（靠近消化器官的腹部狭缝）来减少积液对大脑造成的压力。脑室腹膜（VP）分流术是治疗脑积水最常用的工具之一。根据国家生物技术资讯中心 (NCBI) 发表的一篇研究论文，VP 分流对高级神经外科患者护理有重大影响。 VP 分流术可以挽救良性疾病的生命。

美国脑积水流器市场依年龄层分为儿童和成人。儿科细分市场将在 2022 年引领市场，预计到 2030 年将在预测期内保持主导地位。脑积水是儿童脑部手术最常见的原因。建议进行产前超音波检查或 MRI 扫描来识别生长中胎儿的脑积水。婴儿通常表现出进行性大头畸形的体征，而 2 岁以上的儿童则表现出颅内高压的体征和症状。如果不及时治疗，小儿脑积水可能会很危险。然而，透过早期诊断和治疗，儿童通常可以过着正常、健康的生活。据脑积水协会称，在美国，每 1,000 名婴儿中就有 1-2 名患有脑积水。

美国脑积水流器市场依最终用户划分为医院、门诊手术中心等。医院细分市场将在 2022 年引领市场，预计到 2030 年将在预测期内保持主导地位。医院透过复杂但专业的科学设备为人们提供医疗保健。这些设施分为一般机构、专业机构或政府机构。医院为患有各种疾病的患者群体提供医疗服务，并发挥重要作用。美国医院脑积水流器市场的成长归因于神经外科手术数量的增加，以及这些设施中用于治疗这种情况的瓣膜和神经导航系统的需求激增。此外，已开发国家和发展中国家越来越多的医院提供脑积水手术预计将推动未来市场的成长。

美国脑积水流器市场：关键参与者

B. Braun SE、Sophysa SA、Integra LifeSciences Holdings Corp、KANEKA MEDIX CORP、Medtronic Plc、Natus Medical Inc、Anuncia Inc、Desu Medical 是美国脑积水分流器市场的领先公司。

在准备美国脑积水分流器市场报告时提到的一些主要和次要来源包括世界卫生组织(WHO)、FDA（食品和药物管理局）、脑积水协会、国家神经疾病和中风研究所( NINDS) ）、加州大学、洛杉矶卫生组织、国家生物技术资讯中心、橘郡儿童健康中心等。

目录

第 1 章：简介

• Insight Partners 研究报告指南
• 市场区隔

第 2 章：研究方法

• 覆盖范围
• 二次研究
• 初步研究

第 3 章：美国脑积水流体器市场 - 市场格局

• 概述
  • 美国PEST分析

第 4 章：美国脑积水流体器市场 - 主要市场动态

• 市场驱动因素
  • 脑积水盛行率激增
  • 脑积水治疗设备的进展
• 市场限制
  • 治疗费用高且需要修改手术
• 市场机会
  • 与脑积水流相关的研发和试验经费增加
• 未来的趋势
  • 加强合作以帮助脑积水分流器的智慧运作
• 影响分析

第 5 章：美国脑积水分流器市场 - 国家分析

第 6 章：脑积水流量市场 - 收入和 2030 年预测 - 按产品

• 概述
• 2022 年及 2030 年美国脑积水分流器市场收入份额（按产品划分）
• 脑积水瓣膜
• 脑积水导管
• 神经导航系统
• 其他的

第 7 章：美国脑积水分流器市场 - 收入和 2030 年预测 - 按类型

• 概述
• 美国脑积水分流器市场收入份额，按类型 2022 年和 2030 年 (%)
• 脑室腹膜
• 心室房
• 脑室胸膜
• 腰腹膜

第 8 章：美国脑积水流量市场 - 收入和 2030 年预测 - 按年龄组

• 概述
• 2022 年及 2030 年美国脑积水分流器市场收入份额（按年龄组）（%）
• 儿科
• 成年人

第 9 章：美国脑积水流量市场 - 收入和 2030 年预测 - 按最终用户

• 概述
• 2022 年及 2030 年美国脑积水分流器市场收入份额（按最终用户划分）（%）
• 医院
• 门诊手术中心
• 其他的

第 10 章：产业格局

• 概述
• 有机发展
  • 概述

第 11 章：公司简介

• B. Braun SE
• Sophysa SA
• Integra LifeSciences Holdings Corp
• KANEKA MEDIX CORP.
• Medtronic Plc
• Natus Medical Inc
• Anuncia Inc.
• Desu Medical

第 12 章：附录

• 关于 Insight Partners
• 专业术语

The US Hydrocephalus Shunts market size is expected to reach US$ 0.146 billion by 2030 from US$ 0.109 billion in 2022. The market is estimated to grow at a CAGR of 3.7% from 2022 to 2030.

Market Overview:

There are several treatment options available for hydrocephalus, including:

Shunt Systems: This is a common treatment where a shunt (a thin tube) is implanted to divert excess cerebrospinal fluid from the brain to another part of the body where it can be absorbed. There may have been advancements in shunt technology to improve their effectiveness and reduce complications.

Endoscopic Third Ventriculostomy (ETV): This is a surgical procedure where a small hole is made in the floor of the third ventricle of the brain to allow excess cerebrospinal fluid to flow out and be absorbed. ETV is used in certain cases of non-communicating hydrocephalus.

Ventriculostomy with Catheter: Another surgical option involves inserting a catheter directly into the brain's ventricles to drain excess cerebrospinal fluid.

Intraventricular Endoscopy: Advances in minimally invasive techniques like endoscopy have allowed for more precise diagnosis and treatment of hydrocephalus.

Increasing Partnerships to Treat Hydrocephalus

US hydrocephalus shunts market companies are implementing strategies such as joint ventures and partnerships to extend their market shares. In 2020, Aesculap, Inc., partnered with Christoph Miethke GmbH & Co. KG (MIETHKE), and together they announced the launch of the M.blue hydrocephalus valve in the US. Its unique gravity technology is integrated with a fixed differential pressure unit in a valve, enabling a simple, position-dependent adjustment of the opening pressure during the patient's most active time. Many market players are focused on developing "smart shunts" that could provide an understanding of flow or volume rates over time. Several industry partners are also developing devices that use thermodilution to estimate flow through a distal catheter to diagnose shunt malfunction. Thus, the increasing number of partnerships to aid in smart functioning of hydrocephalus shunts would lead to new future trends in the US hydrocephalus shunts market.

Growing Research to Improve the Quality of Shunts

Researchers have been developing improved shunts materials to reduce the risk of blockages, infections, and other complications.

Antibacterial Coatings: Researchers have been investigating coatings for shunts that have antibacterial properties. These coatings can help reduce the risk of infection when the shunt is implanted.

Anti-Blockage Mechanisms: Some shunt designs incorporate features to prevent or mitigate blockages. For example, valves with anti-siphon mechanisms can help maintain proper flow and prevent over-drainage or blockages.

Magnetic Valve Adjustments: Some shunt systems use magnets to adjust valve settings non-invasively, reducing the need for repeated surgeries.

Biocompatible Materials: The use of biocompatible materials in shunt construction can minimize the risk of allergic reactions or other adverse responses from the body.

Remote Monitoring: Advancements in remote monitoring technology have allowed for tracking shunt performance and intracranial pressure, helping healthcare providers identify issues before they become severe.

Nanotechnology: Nanotechnology applications have been explored for creating shunt components that resist bacterial adhesion and improve the overall durability of the shunt.

For instance, in 2021, Penn State researchers have been actively working on a groundbreaking technology called HydroFix. This innovative surgical shunt system is specifically designed to address the numerous risks associated with existing shunt devices available in the market. Its primary aim is to offer a long-lasting treatment solution for patients with Normal Pressure Hydrocephalus (NPH). To advance this technology, the researchers established a startup called Cranial Devices Inc. They are currently in the process of seeking a license for the HydroFix technology from Penn State University.

Similarly, Rhaeos, Inc., a clinical-stage medical device company, is developing FlowSense, a patented technology and a noninvasive wireless, wearable skin patch. FlowSense is a wireless, noninvasive thermal flow sensor that is mounted on a patient's neck overlying the shunt to detect the presence and magnitude of CSF. With FlowSense, shunt function can be monitored in clinics, in-patient settings, and emergency departments, thereby reducing unnecessary imaging, hospital length of stay, and readmission costs.

US Hydrocephalus Shunts Market: Segmental Overview

The US hydrocephalus shunts market growth is segmented into product, type, age group, and end-user. On the basis of product, the market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves is further segmented into adjustable pressure valves, and fix pressure valves. In terms of type, the US hydrocephalus shunts market is segmented into ventriculoperitoneal, ventriculoatrial, ventriculopleural, and lumboperitoneal. The ventriculoperitoneal segment led the market in 2022 and is expected to retain its dominance during the forecast period. A ventriculoperitoneal (VP) shunt reduces pressure exerted on the brain by fluid accumulation by diverting CSF from the brain's ventricles into the peritoneal cavity, the slot in the abdomen near digestive organs. Ventriculoperitoneal (VP) shunts are among the most commonly used tools for treating hydrocephalus. According to a research paper published in the National Center for Biotechnology Information (NCBI), a VP shunt has a high impact in advanced neurosurgical patient care. VP shunt can be lifesaving for benign disorders.

The US hydrocephalus shunts market, by age group, is segmented into pediatric and adults. The pediatric segment led the market in 2022 and is expected to retain its dominance during the forecast period by 2030. Hydrocephalus is the most common cause of brain surgery in children. A prenatal sonogram or MRI scan is recommended to identify hydrocephalus in a growing fetus. Infants generally show signs of progressive macrocephaly, whereas children older than 2 years show signs and symptoms of intracranial hypertension. Pediatric hydrocephalus can be dangerous if left untreated. Nevertheless, with early diagnosis and treatment, children often lead regular and healthy lives. According to the Hydrocephalus Association, 1-2 of every 1,000 babies have hydrocephalus in the US.

The US hydrocephalus shunts market, by end user, is segmented into hospitals, ambulatory surgical centers, others. The hospitals segment led the market in 2022 and is expected to retain its dominance during the forecast period by 2030. Hospitals provide healthcare to people through complicated but specialized scientific equipment. These facilities are classified into general, specialty, or government organizations. Hospitals serve a significant role by providing medical services to patient populations suffering from various diseases. The growth of the US hydrocephalus shunt market for the hospitals segment is attributed to an increase in the number of neurological surgeries, and a surge in demand for valves and neuronavigation systems in these facilities to treat the condition. Additionally, an increasing number of hospitals providing hydrocephalus surgeries in developed and developing countries is expected to boost the market growth in the future.

US Hydrocephalus Shunts Market: Key Players

B. Braun SE, Sophysa SA, Integra LifeSciences Holdings Corp, KANEKA MEDIX CORP, Medtronic Plc, Natus Medical Inc, Anuncia Inc, Desu Medical are among the leading companies operating in the US hydrocephalus shunts market.

A few of the key primary and secondary sources referred to while preparing the report on the US hydrocephalus shunts market are the World Health Organization (WHO), FDA (Food and Drug Administration), Hydrocephalus Association, National Institute of Neurological Disorders and Stroke (NINDS), University of California, Los Angeles Health Organization, National Center for Biotechnology Information, Children's Health Orange County, amongst others.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hydrocephalus shunts market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the US hydrocephalus shunts market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth US market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Research Methodology

• 2.1 Coverage
• 2.2 Secondary Research
• 2.3 Primary Research

3. US Hydrocephalus Shunts Market - Market Landscape

• 3.1 Overview
  • 3.1.1 US PEST Analysis

4. US Hydrocephalus Shunts Market - Key Market Dynamics

• 4.1 Market Drivers
  • 4.1.1 Surging Prevalence of Hydrocephalus
  • 4.1.2 Advancements in Hydrocephalus Management Devices
• 4.2 Market Restraints
  • 4.2.1 High Cost of Treatments and Need for Revised Surgeries
• 4.3 Market Opportunities
  • 4.3.1 Rise in Funding for R&D and Trials Associated with Hydrocephalus Shunts
• 4.4 Future Trends
  • 4.4.1 Increasing Partnerships to Aid in Smart Functioning of Hydrocephalus Shunts
• 4.5 Impsact Analysis

5. US Hydrocephalus Shunts Market - Country Analysis

• 5.1 US Hydrocephalus Shunts Market
  • 5.1.1 Overview

6. Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by Product

• 6.1 Overview
• 6.2 US Hydrocephalus Shunts Market Revenue Share, by Product 2022 & 2030 (%)
• 6.3 Hydrocephalus Valves
  • 6.3.1 Overview
  • 6.3.2 Hydrocephalus Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.1 Adjustable Pressure Valves
      • 6.3.2.1.1 Overview
      • 6.3.2.1.2 Adjustable Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.2 Fix Pressure Valves
      • 6.3.2.2.1 Overview
      • 6.3.2.2.2 Fix Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Hydrocephalus Catheters
  • 6.4.1 Overview
  • 6.4.2 Hydrocephalus Catheters: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 6.5 Neuronavigation Systems
  • 6.5.1 Overview
  • 6.5.2 Neuronavigation Systems: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 6.6 Others
  • 6.6.1 Overview
  • 6.6.2 Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

7. US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by Type

• 7.1 Overview
• 7.2 US Hydrocephalus Shunts Market Revenue Share, by Type 2022 & 2030 (%)
• 7.3 Ventriculoperitoneal
  • 7.3.1 Overview
  • 7.3.2 Ventriculoperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Ventriculoatrial
  • 7.4.1 Overview
  • 7.4.2 Ventriculoatrial: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Ventriculopleural
  • 7.5.1 Overview
  • 7.5.2 Ventriculopleural: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Lumboperitoneal
  • 7.6.1 Overview
  • 7.6.2 Lumboperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

8. US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by Age Group

• 8.1 Overview
• 8.2 US Hydrocephalus Shunts Market Revenue Share, by Age Group 2022 & 2030 (%)
• 8.3 Pediatric
  • 8.3.1 Overview
  • 8.3.2 Pediatric: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Adults
  • 8.4.1 Overview
  • 8.4.2 Adults: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

9. US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by End User

• 9.1 Overview
• 9.2 US Hydrocephalus Shunts Market Revenue Share, by End User 2022 & 2030 (%)
• 9.3 Hospitals
  • 9.3.1 Overview
  • 9.3.2 Hospitals: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Ambulatory Surgical Centers
  • 9.4.1 Overview
  • 9.4.2 Ambulatory Surgical Centers: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Others
  • 9.5.1 Overview
  • 9.5.2 Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

10. Industry Landscape

• 10.1 Overview
• 10.2 Organic Developments
  • 10.2.1 Overview

11. Company Profiles

• 11.1 B. Braun SE
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 Sophysa SA
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 Integra LifeSciences Holdings Corp
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 KANEKA MEDIX CORP.
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 Medtronic Plc
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 Natus Medical Inc
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments
• 11.7 Anuncia Inc.
  • 11.7.1 Key Facts
  • 11.7.2 Business Description
  • 11.7.3 Products and Services
  • 11.7.4 Financial Overview
  • 11.7.5 SWOT Analysis
  • 11.7.6 Key Developments
• 11.8 Desu Medical
  • 11.8.1 Key Facts
  • 11.8.2 Business Description
  • 11.8.3 Products and Services
  • 11.8.4 Financial Overview
  • 11.8.5 SWOT Analysis
  • 11.8.6 Key Developments

12. Appendix

• 12.1 About The Insight Partners
• 12.2 Glossary of Terms

List Of Tables

• Table 1. Organic Developments Done by Companies
• Table 2. Glossary of Terms

List Of Figures

• Figure 1. US Hydrocephalus Shunts Market Segmentation
• Figure 2. US Hydrocephalus Shunts Market - Key Takeaways
• Figure 3. US: PEST Analysis
• Figure 4. Hydrocephalus Shunts Market: Key Industry Dynamics
• Figure 5. US Hydrocephalus Shunts Market Impact Analysis of Drivers and Restraints
• Figure 6. US Hydrocephalus Shunts Market - Revenue Forecast and Analysis - 2020-2030
• Figure 7. US Hydrocephalus Shunts Market Revenue Share, by Product 2022 & 2030 (%)
• Figure 8. Hydrocephalus Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 9. Adjustable Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 10. Fix Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 11. Hydrocephalus Catheters: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Neuronavigation Systems: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 14. US Hydrocephalus Shunts Market Revenue Share, by Type 2022 & 2030 (%)
• Figure 15. Ventriculoperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. Ventriculoatrial: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 17. Ventriculopleural: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 18. Lumboperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. US Hydrocephalus Shunts Market Revenue Share, by Age Group 2022 & 2030 (%)
• Figure 20. Pediatric: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 21. Adults: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22. US Hydrocephalus Shunts Market Revenue Share, by End User 2022 & 2030 (%)
• Figure 23. Hospitals: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24. Ambulatory Surgical Centers: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 25. Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)